Company
United StatesWaylis Therapeutics, Rahway, NJ – FDA Inspections
Inspection records and compliance data for Waylis Therapeutics in Rahway, New Jersey. 1 FDA inspection on record, 1 Form 483, last inspected February 12, 2026.
Company Profile
This profile covers Waylis Therapeutics based in Rahway, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected February 12, 2026.
Most cited issue areas
- Failure to develop written procedures1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 12, 2026 | Not classified | Human Drugs · Postmarketing Surveillance and Epidemiology: Human Drugs | 1303428 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Waylis Therapeutics
FEI Number
3021614574
Address
2131 Felver Court Suite B, Rahway, New Jersey, United States
Country
United States
ID: 3d1c452a-fef8-4404-a314-dc9fb6038b9b